Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients
The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin...
Gespeichert in:
Veröffentlicht in: | Brain (London, England : 1878) England : 1878), 2004-02, Vol.127 (2), p.439-451 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 451 |
---|---|
container_issue | 2 |
container_start_page | 439 |
container_title | Brain (London, England : 1878) |
container_volume | 127 |
creator | Selcen, Duygu Ohno, Kinji Engel, Andrew G. |
description | The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and αBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long‐standing diabetes. The abnormal muscle fibres are best identified in trichrome‐stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, αBC, dystrophin and β‐amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z‐disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and αBC, as well as in telethonin, a Z‐disk‐associated protein, or in syncoilin, which together with plectin links desmin to the Z‐disk. Two of the 63 patients carry truncation mutations in the C‐terminal domain of αBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z‐disk. |
doi_str_mv | 10.1093/brain/awh052 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80102627</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>729136601</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-212e81adf6246d4e3da91447200c9d7921e43b797a446365ecd7597e918718853</originalsourceid><addsrcrecordid>eNqF0c9rFDEUB_Agit1Wb54lCPbUsXn5OelNi1pxqwgq4iVkM5lu6kyyJjPo_vem3cWCF08h5JOX9_JF6AmQF0A0O11lG-Kp_bUmgt5DC-CSNBSEvI8WhBDZtFqQA3RYyjUhwBmVD9EBcAXQtnSBPl1uUx9WOQyDzXjcpo2d1tsz7IYQg7PDCR5T3qzTkK5uttjGDl_56KfgcJnmLviCQ8SS4Xox-DiVR-hBb4fiH-_XI_TlzevP5xfN8uPbd-cvl40ToKbaIvUt2K6XlMuOe9ZZDZwrSojTndIUPGcrpZXlXDIpvOuU0MpraFVtXbAjdLyru8np5-zLZMZQnK9zRJ_mYloChEqq_gtB10dbBhU--wdepznHOkQ1glOtOanoZIdcTqVk35tNDqPNWwPE3ARibgMxu0Aqf7qvOa9G393hfQIVPN8DW-oH99lGF8qdE5wxuHXNzoUy-d9_z23-YaRiSpiLb98Nf3-5fPUBvhrK_gA8t6H_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195429940</pqid></control><display><type>article</type><title>Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Selcen, Duygu ; Ohno, Kinji ; Engel, Andrew G.</creator><creatorcontrib>Selcen, Duygu ; Ohno, Kinji ; Engel, Andrew G.</creatorcontrib><description>The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and αBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long‐standing diabetes. The abnormal muscle fibres are best identified in trichrome‐stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, αBC, dystrophin and β‐amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z‐disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and αBC, as well as in telethonin, a Z‐disk‐associated protein, or in syncoilin, which together with plectin links desmin to the Z‐disk. Two of the 63 patients carry truncation mutations in the C‐terminal domain of αBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z‐disk.</description><identifier>ISSN: 0006-8950</identifier><identifier>ISSN: 1460-2156</identifier><identifier>EISSN: 1460-2156</identifier><identifier>DOI: 10.1093/brain/awh052</identifier><identifier>PMID: 14711882</identifier><identifier>CODEN: BRAIAK</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adolescent ; Adult ; Age of Onset ; Aged ; Aged, 80 and over ; alpha-Crystallin B Chain - genetics ; Aβ = β‐amyloid protein ; Biological and medical sciences ; CDC = cell division cycle ; Child ; Connectin ; Cytoskeletal Proteins ; desmin ; Desmin - genetics ; Disease Progression ; DNA Mutational Analysis ; Female ; Humans ; KPI = Kunitz protease inhibitor ; LGMD = limb‐girdle muscular dystrophy ; Male ; Medical sciences ; MFM = myofibrillar myopathy ; Microscopy, Electron ; Middle Aged ; MUP = motor unit potential ; Muscle Proteins - genetics ; Muscle Proteins - metabolism ; Muscular Diseases - diagnosis ; Muscular Diseases - genetics ; Muscular Diseases - metabolism ; Muscular Diseases - pathology ; Mutation ; mutation analysis ; myofibrillar myopathy ; Myofibrils - metabolism ; Myofibrils - ultrastructure ; NCAM = neural cell adhesion molecule ; Neural Conduction ; Neurology ; Z‐disk ; αBC = αB‐crystallin ; αB‐crystallin ; βAPP = β‐amyloid precursor protein</subject><ispartof>Brain (London, England : 1878), 2004-02, Vol.127 (2), p.439-451</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Feb 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-212e81adf6246d4e3da91447200c9d7921e43b797a446365ecd7597e918718853</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15433182$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14711882$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Selcen, Duygu</creatorcontrib><creatorcontrib>Ohno, Kinji</creatorcontrib><creatorcontrib>Engel, Andrew G.</creatorcontrib><title>Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients</title><title>Brain (London, England : 1878)</title><addtitle>Brain</addtitle><description>The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and αBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long‐standing diabetes. The abnormal muscle fibres are best identified in trichrome‐stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, αBC, dystrophin and β‐amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z‐disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and αBC, as well as in telethonin, a Z‐disk‐associated protein, or in syncoilin, which together with plectin links desmin to the Z‐disk. Two of the 63 patients carry truncation mutations in the C‐terminal domain of αBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z‐disk.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>alpha-Crystallin B Chain - genetics</subject><subject>Aβ = β‐amyloid protein</subject><subject>Biological and medical sciences</subject><subject>CDC = cell division cycle</subject><subject>Child</subject><subject>Connectin</subject><subject>Cytoskeletal Proteins</subject><subject>desmin</subject><subject>Desmin - genetics</subject><subject>Disease Progression</subject><subject>DNA Mutational Analysis</subject><subject>Female</subject><subject>Humans</subject><subject>KPI = Kunitz protease inhibitor</subject><subject>LGMD = limb‐girdle muscular dystrophy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MFM = myofibrillar myopathy</subject><subject>Microscopy, Electron</subject><subject>Middle Aged</subject><subject>MUP = motor unit potential</subject><subject>Muscle Proteins - genetics</subject><subject>Muscle Proteins - metabolism</subject><subject>Muscular Diseases - diagnosis</subject><subject>Muscular Diseases - genetics</subject><subject>Muscular Diseases - metabolism</subject><subject>Muscular Diseases - pathology</subject><subject>Mutation</subject><subject>mutation analysis</subject><subject>myofibrillar myopathy</subject><subject>Myofibrils - metabolism</subject><subject>Myofibrils - ultrastructure</subject><subject>NCAM = neural cell adhesion molecule</subject><subject>Neural Conduction</subject><subject>Neurology</subject><subject>Z‐disk</subject><subject>αBC = αB‐crystallin</subject><subject>αB‐crystallin</subject><subject>βAPP = β‐amyloid precursor protein</subject><issn>0006-8950</issn><issn>1460-2156</issn><issn>1460-2156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c9rFDEUB_Agit1Wb54lCPbUsXn5OelNi1pxqwgq4iVkM5lu6kyyJjPo_vem3cWCF08h5JOX9_JF6AmQF0A0O11lG-Kp_bUmgt5DC-CSNBSEvI8WhBDZtFqQA3RYyjUhwBmVD9EBcAXQtnSBPl1uUx9WOQyDzXjcpo2d1tsz7IYQg7PDCR5T3qzTkK5uttjGDl_56KfgcJnmLviCQ8SS4Xox-DiVR-hBb4fiH-_XI_TlzevP5xfN8uPbd-cvl40ToKbaIvUt2K6XlMuOe9ZZDZwrSojTndIUPGcrpZXlXDIpvOuU0MpraFVtXbAjdLyru8np5-zLZMZQnK9zRJ_mYloChEqq_gtB10dbBhU--wdepznHOkQ1glOtOanoZIdcTqVk35tNDqPNWwPE3ARibgMxu0Aqf7qvOa9G393hfQIVPN8DW-oH99lGF8qdE5wxuHXNzoUy-d9_z23-YaRiSpiLb98Nf3-5fPUBvhrK_gA8t6H_</recordid><startdate>20040201</startdate><enddate>20040201</enddate><creator>Selcen, Duygu</creator><creator>Ohno, Kinji</creator><creator>Engel, Andrew G.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20040201</creationdate><title>Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients</title><author>Selcen, Duygu ; Ohno, Kinji ; Engel, Andrew G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-212e81adf6246d4e3da91447200c9d7921e43b797a446365ecd7597e918718853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>alpha-Crystallin B Chain - genetics</topic><topic>Aβ = β‐amyloid protein</topic><topic>Biological and medical sciences</topic><topic>CDC = cell division cycle</topic><topic>Child</topic><topic>Connectin</topic><topic>Cytoskeletal Proteins</topic><topic>desmin</topic><topic>Desmin - genetics</topic><topic>Disease Progression</topic><topic>DNA Mutational Analysis</topic><topic>Female</topic><topic>Humans</topic><topic>KPI = Kunitz protease inhibitor</topic><topic>LGMD = limb‐girdle muscular dystrophy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MFM = myofibrillar myopathy</topic><topic>Microscopy, Electron</topic><topic>Middle Aged</topic><topic>MUP = motor unit potential</topic><topic>Muscle Proteins - genetics</topic><topic>Muscle Proteins - metabolism</topic><topic>Muscular Diseases - diagnosis</topic><topic>Muscular Diseases - genetics</topic><topic>Muscular Diseases - metabolism</topic><topic>Muscular Diseases - pathology</topic><topic>Mutation</topic><topic>mutation analysis</topic><topic>myofibrillar myopathy</topic><topic>Myofibrils - metabolism</topic><topic>Myofibrils - ultrastructure</topic><topic>NCAM = neural cell adhesion molecule</topic><topic>Neural Conduction</topic><topic>Neurology</topic><topic>Z‐disk</topic><topic>αBC = αB‐crystallin</topic><topic>αB‐crystallin</topic><topic>βAPP = β‐amyloid precursor protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Selcen, Duygu</creatorcontrib><creatorcontrib>Ohno, Kinji</creatorcontrib><creatorcontrib>Engel, Andrew G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain (London, England : 1878)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Selcen, Duygu</au><au>Ohno, Kinji</au><au>Engel, Andrew G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients</atitle><jtitle>Brain (London, England : 1878)</jtitle><addtitle>Brain</addtitle><date>2004-02-01</date><risdate>2004</risdate><volume>127</volume><issue>2</issue><spage>439</spage><epage>451</epage><pages>439-451</pages><issn>0006-8950</issn><issn>1460-2156</issn><eissn>1460-2156</eissn><coden>BRAIAK</coden><abstract>The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and αBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long‐standing diabetes. The abnormal muscle fibres are best identified in trichrome‐stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, αBC, dystrophin and β‐amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z‐disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and αBC, as well as in telethonin, a Z‐disk‐associated protein, or in syncoilin, which together with plectin links desmin to the Z‐disk. Two of the 63 patients carry truncation mutations in the C‐terminal domain of αBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z‐disk.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>14711882</pmid><doi>10.1093/brain/awh052</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-8950 |
ispartof | Brain (London, England : 1878), 2004-02, Vol.127 (2), p.439-451 |
issn | 0006-8950 1460-2156 1460-2156 |
language | eng |
recordid | cdi_proquest_miscellaneous_80102627 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Adolescent Adult Age of Onset Aged Aged, 80 and over alpha-Crystallin B Chain - genetics Aβ = β‐amyloid protein Biological and medical sciences CDC = cell division cycle Child Connectin Cytoskeletal Proteins desmin Desmin - genetics Disease Progression DNA Mutational Analysis Female Humans KPI = Kunitz protease inhibitor LGMD = limb‐girdle muscular dystrophy Male Medical sciences MFM = myofibrillar myopathy Microscopy, Electron Middle Aged MUP = motor unit potential Muscle Proteins - genetics Muscle Proteins - metabolism Muscular Diseases - diagnosis Muscular Diseases - genetics Muscular Diseases - metabolism Muscular Diseases - pathology Mutation mutation analysis myofibrillar myopathy Myofibrils - metabolism Myofibrils - ultrastructure NCAM = neural cell adhesion molecule Neural Conduction Neurology Z‐disk αBC = αB‐crystallin αB‐crystallin βAPP = β‐amyloid precursor protein |
title | Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A22%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myofibrillar%20myopathy:%20clinical,%20morphological%20and%20genetic%20studies%20in%2063%20patients&rft.jtitle=Brain%20(London,%20England%20:%201878)&rft.au=Selcen,%20Duygu&rft.date=2004-02-01&rft.volume=127&rft.issue=2&rft.spage=439&rft.epage=451&rft.pages=439-451&rft.issn=0006-8950&rft.eissn=1460-2156&rft.coden=BRAIAK&rft_id=info:doi/10.1093/brain/awh052&rft_dat=%3Cproquest_cross%3E729136601%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195429940&rft_id=info:pmid/14711882&rfr_iscdi=true |